Healthcare -
Biotechnology - NASDAQ - US
$ 7.9
0.381 %
$ 1.64 B
Market Cap
-12.95
P/E
BCRX - SHORT-TERM DEBT
Short-term Debt BCRX - BioCryst Pharmaceuticals, Inc.
2.65 M
LAST VALUE
20.65%
2 YEAR CAGR
-39.89%
5 YEAR CAGR
0.00%
10 YEAR CAGR